Total Payments
$13,604
2024 Payments
$4,433
Companies
38
Transactions
662
Medicare Patients
1,882
Medicare Billing
$171,126
Payment Breakdown by Category
Food & Beverage$13,458 (98.9%)
Education$145.57 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,458 | 654 | 98.9% |
| Education | $145.57 | 8 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,366 | 122 | $0 (2024) |
| Novo Nordisk Inc | $1,626 | 83 | $0 (2024) |
| Dexcom, Inc. | $1,523 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,099 | 49 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $982.12 | 60 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $699.98 | 26 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $640.54 | 34 | $0 (2024) |
| Amgen Inc. | $569.43 | 30 | $0 (2024) |
| Corcept Therapeutics | $552.21 | 33 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $431.31 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,433 | 209 | Lilly USA, LLC ($781.23) |
| 2023 | $3,798 | 182 | Lilly USA, LLC ($836.31) |
| 2022 | $2,886 | 137 | Lilly USA, LLC ($553.08) |
| 2021 | $2,487 | 134 | Novo Nordisk Inc ($382.80) |
All Payment Transactions
662 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/18/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $42.34 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Bone Health | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/27/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.88 | General |
| 11/26/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $42.34 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Biological | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Bone Health | ||||||
| 11/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 516 | 888 | $139,875 | $52,895 |
| 2022 | 4 | 361 | 552 | $93,867 | $37,082 |
| 2021 | 6 | 468 | 648 | $102,971 | $44,856 |
| 2020 | 6 | 537 | 684 | $100,846 | $36,292 |
Total Patients
1,882
Total Services
2,772
Medicare Billing
$171,126
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 303 | 543 | $108,600 | $41,902 | 38.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 125 | 254 | $14,679 | $5,453 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,300 | $2,716 | 32.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 21 | 21 | $4,926 | $2,210 | 44.9% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 11 | 11 | $2,750 | $515.68 | 18.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 28 | 31 | $620.00 | $99.51 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 217 | 349 | $69,800 | $27,491 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $9,300 | $3,332 | 35.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 87 | 146 | $8,437 | $3,210 | 38.0% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 26 | 26 | $6,329 | $3,050 | 48.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 353 | $70,600 | $31,271 | 44.3% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 35 | 37 | $9,007 | $4,896 | 54.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $8,700 | $3,379 | 38.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 81 | 113 | $6,530 | $2,821 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 58 | $6,973 | $2,298 | 33.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 42 | 58 | $1,160 | $190.24 | 16.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 249 | 348 | $69,208 | $24,348 | 35.2% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2020 | 30 | 30 | $7,369 | $3,720 | 50.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $8,464 | $3,220 | 38.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 75 | 81 | $9,818 | $3,035 | 30.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 50 | 58 | $3,366 | $1,515 | 45.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 105 | 139 | $2,620 | $453.40 | 17.3% |
About Rubylyn Hilario, FNP-BC
Rubylyn Hilario, FNP-BC is a Family healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2019. The National Provider Identifier (NPI) number assigned to this provider is 1952862104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rubylyn Hilario, FNP-BC has received a total of $13,604 in payments from pharmaceutical and medical device companies, with $4,433 received in 2024. These payments were reported across 662 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($13,458).
As a Medicare-enrolled provider, Hilario has provided services to 1,882 Medicare beneficiaries, totaling 2,772 services with total Medicare billing of $171,126. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Elgin, IL
- Active Since 03/29/2019
- Last Updated 03/29/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952862104
Products in Payments
- JARDIANCE (Drug) $1,681
- Dexcom G6 Transmitter (Medical Supply) $1,351
- UNITHROID (Drug) $982.12
- TRULICITY (Drug) $732.89
- MOUNJARO (Drug) $703.36
- Kerendia (Drug) $699.98
- Korlym (Drug) $552.21
- Ozempic (Drug) $497.00
- EVENITY (Biological) $491.34
- Rybelsus (Drug) $449.53
- AFREZZA (Drug) $366.04
- TZIELD (Biological) $318.00
- FARXIGA (Drug) $286.18
- Wegovy (Drug) $262.54
- RECORLEV (Drug) $246.58
- GVOKE HYPOPEN (Drug) $246.19
- STRENSIQ (Biological) $233.90
- FREESTYLE LIBRE 3 (Device) $180.40
- NEXLETOL (Drug) $175.62
- DEXCOM G6 TRANSMITTER (Device) $172.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Elgin
Catherine Chase, Apn, APN
Family — Payments: $44,505
Family $44,505
Josh Lopez
Family — Payments: $7,931
Family $7,931
Elise Lynch, Apn, APN
Family — Payments: $4,696
Family $4,696
Kate Brink, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $3,552
Family $3,552
Sharon Bode, Fnp, FNP
Family — Payments: $3,521
Family $3,521
Juan Mercado, Apn, APN
Family — Payments: $3,364
Family $3,364